BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

724 related articles for article (PubMed ID: 19894640)

  • 1. Pathophysiological concepts of functional dyspepsia and irritable bowel syndrome future pharmacotherapy.
    Dobrek Ł; Thor PJ
    Acta Pol Pharm; 2009; 66(5):447-60. PubMed ID: 19894640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria.
    Wang A; Liao X; Xiong L; Peng S; Xiao Y; Liu S; Hu P; Chen M
    BMC Gastroenterol; 2008 Sep; 8():43. PubMed ID: 18808723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intolerance to visceral distension in functional dyspepsia or irritable bowel syndrome: an organ specific defect or a pan intestinal dysregulation?
    Bouin M; Lupien F; Riberdy M; Boivin M; Plourde V; Poitras P
    Neurogastroenterol Motil; 2004 Jun; 16(3):311-4. PubMed ID: 15198653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recent insights into the pathogenesis of abdominal symptoms in functional bowel disorders].
    Cervio E; Rondanelli M; Balestra B; Dellabianca A; Agazzi A; Giacosa A; Tonini M
    Recenti Prog Med; 2007 Feb; 98(2):69-73. PubMed ID: 17439064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Definition and epidemiology of functional gastrointestinal disorders.
    Corazziari E
    Best Pract Res Clin Gastroenterol; 2004 Aug; 18(4):613-31. PubMed ID: 15324703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New-generation 5-HT4 receptor agonists: potential for treatment of gastrointestinal motility disorders.
    Manabe N; Wong BS; Camilleri M
    Expert Opin Investig Drugs; 2010 Jun; 19(6):765-75. PubMed ID: 20408739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy for functional gastrointestinal disorders in children.
    Chitkara DK; Di Lorenzo C
    Curr Opin Pharmacol; 2006 Dec; 6(6):536-40. PubMed ID: 16949871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to improve drug development for functional disorders.
    Tack J; Corsetti M
    Best Pract Res Clin Gastroenterol; 2004 Aug; 18(4):787-96. PubMed ID: 15324714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Rome III Classification of dyspepsia: will it help research?
    Talley NJ; Ruff K; Jiang X; Jung HK
    Dig Dis; 2008; 26(3):203-9. PubMed ID: 18463436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidimensionality of symptom complexes in irritable bowel syndrome and other functional gastrointestinal disorders.
    Alpers DH
    J Psychosom Res; 2008 Jun; 64(6):567-72. PubMed ID: 18501256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phytotherapy for functional dyspepsia: a review of the clinical evidence for the herbal preparation STW 5.
    Rösch W; Liebregts T; Gundermann KJ; Vinson B; Holtmann G
    Phytomedicine; 2006; 13 Suppl 5():114-21. PubMed ID: 16978851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectra of functional gastrointestinal disorders diagnosed by Rome III integrative questionnaire in a Japanese outpatient office and the impact of overlapping.
    Nakajima S; Takahashi K; Sato J; Fukuda M; Yamamoto K; Inoue T; Okumura Y; Fujiyama Y
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S138-43. PubMed ID: 20586856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Visceral sensitivity disturbances in the pathogenesis of functional gastrointestinal disorders].
    Mazur M; Furgała A; Thor PJ
    Folia Med Cracov; 2004; 45(1-2):33-49. PubMed ID: 16276824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of drugs for gastrointestinal motor disorders: translating science to clinical need.
    Sanger GJ; Alpers DH
    Neurogastroenterol Motil; 2008 Mar; 20(3):177-84. PubMed ID: 18257767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: the overlap between functional dyspepsia and irritable bowel syndrome -- a tale of one or two disorders?
    Cremonini F; Talley NJ
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():40-9. PubMed ID: 15521854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological treatment of irritable bowel syndrome--from concept to sales.
    Kamm MA
    Eur J Surg Suppl; 2002; (587):10-5. PubMed ID: 16144196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The balancing act: endogenous modulation of pain in functional gastrointestinal disorders.
    Wilder-Smith CH
    Gut; 2011 Nov; 60(11):1589-99. PubMed ID: 21768212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The brain--gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study.
    Koloski NA; Jones M; Kalantar J; Weltman M; Zaguirre J; Talley NJ
    Gut; 2012 Sep; 61(9):1284-90. PubMed ID: 22234979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current medical treatments of dyspepsia and irritable bowel syndrome.
    Camilleri M; Tack JF
    Gastroenterol Clin North Am; 2010 Sep; 39(3):481-93. PubMed ID: 20951913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs acting on serotonin receptors for the treatment of functional GI disorders.
    Tonini M; Pace F
    Dig Dis; 2006; 24(1-2):59-69. PubMed ID: 16699264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.